DC
LXRX icon

Deere & Company’s Lexicon Pharmaceuticals LXRX Stock Holding History

Deere & Company’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-29,077
Closed -$417K – 1063
2016
Q2 		$417K Sell
29,077
-13,595
-32% -$184K 0.02% 730
2016
Q1 		$510K Buy
42,672
+21,617
+103% +$227K 0.03% 588
2015
Q4 		$280K Hold
21,055
– – 0.02% 736
2015
Q3 		$226K Buy
+21,055
New +$230K 0.01% 807

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Deere & Company's LXRX Position: Q3 2016 in Review

Deere & Company sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2016, closing a stake of 29,077 shares — an estimated $417K sold.

Deere & Company first reported a position in LXRX in Q3 2015 and held it in 4 quarters. The position peaked at $510K in Q1 2016. 144 funds tracked by Wall St. Rank hold LXRX as of Q3 2016.

  • Deere & Company reported no remaining Lexicon Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 29,077 Lexicon Pharmaceuticals shares in Q3 2016, an estimated $417K.
  • Deere & Company first reported a position in Lexicon Pharmaceuticals in Q3 2015 and held it in 4 quarters.
  • Deere & Company's Lexicon Pharmaceuticals position peaked at $510K in Q1 2016.
  • 144 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.